Turbine

Company profile

About Turbine

Turbine is a biotechnology AI company that has built a Virtual Lab platform for simulating biological experiments at unprecedented scale. Founded in 2016 and headquartered in Budapest, Hungary, Turbine serves leading biopharma companies including MSD (Merck & Co.), AstraZeneca, Bayer, and Ono Pharmaceutical. The company's platform enables scientists to simulate millions of experiments per day on virtual disease models, dramatically accelerating drug discovery timelines and improving success rates. Turbine's Virtual Lab includes over 1,400 oncology cell lines, 1,200 payloads and drug molecules, and knockout alterations across 8,500+ genes. The platform supports multiple use cases including target discovery, combination design, ADC positioning, biomarker selection, clinical positioning, and indication expansion. By virtualizing experiments before conducting wet lab work, Turbine helps partners make better R&D decisions repeatedly, with claims of 1.5x higher validation success rates and 2x faster timelines from scientific question to validation. The company offers tiered access from self-serve simulations on public datasets (vLab Core) to fully integrated collaborative platforms with proprietary data (vLab Collaborate) and wet lab validation loops. Turbine has raised over $60M in funding through Series B, backed by investors including Accel, MSD Global Health Innovation Fund, XTX Ventures, and Accenture Ventures. The company employs over 80 people across multiple European countries and the United States.

Company description · Turbine official website